<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" version="2.0" xml:base="https://rtaylor193.github.io/insureintell-1col/">
  <channel>
    <title>Hypertrophic Cardiomyopathy</title>
    <link>https://rtaylor193.github.io/insureintell-1col/</link>
    <description/>
    <language>en</language>
    
    <item>
  <title>An Update on Hypertrophic Cardiomyopathy</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25904</link>
  <description>&lt;span&gt;An Update on Hypertrophic Cardiomyopathy&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Mon, 09/11/2017&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;This article will provide a contemporary perspective of HCM, including potential treatment modalities and how its risk is currently stratified.&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Link&lt;/div&gt;
              &lt;div&gt;&lt;a href="http://www.rgare.com/docs/default-source/newsletters-articles/reflections-vol-42-sept-2017_final7632c58ec5e163acbc5dff0000ff1aaa.pdf?sfvrsn=0"&gt;An Update on Hypertrophic Cardiomyopathy&lt;/a&gt;&lt;/div&gt;
          &lt;/div&gt;

  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/193" hreflang="en"&gt;Hypertrophic Cardiomyopathy&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Mon, 11 Sep 2017 22:32:54 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">25904 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>
<item>
  <title>Hypertrophic Cardiomyopathy vs Athletic Heart Syndrome</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25316</link>
  <description>&lt;span&gt;Hypertrophic Cardiomyopathy vs Athletic Heart Syndrome&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Thu, 05/26/2016&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;In life insurance underwriting, it is important to recognize the differences between hypertrophic cardiomyopathy (HCM) and the benign heart enlargement of an athlete.&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/192" hreflang="en"&gt;athletic heart syndrome&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/193" hreflang="en"&gt;Hypertrophic Cardiomyopathy&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Thu, 26 May 2016 19:52:25 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">25316 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>

  </channel>
</rss>
